ResMed Tops Expectations but Falls Anyway
Medical-device maker ResMed (NYSE: RMD) reported its fiscal fourth-quarter results after the market closed on Tuesday, Aug. 1. The continuous positive airway pressure (CPAP) pioneer reported modest top-line growth when compared with last quarter, but margin improvements help drive better-than-expected results on the bottom line.
Let's take a closer look at the company's results to get a better sense of how it fared during the period.
Image source: Getty Images.
Source: Fool.com
Resmed Inc. Stock
€221.70
0.050%
With 21 Buy predictions and not a single Sell prediction Resmed Inc. is an absolute favorite of our community.
On the other hand, the target price of 216 € is below the current price of 221.7 € for Resmed Inc., so the potential is actually -2.57%.
